target customers and , acquisitions of additional motion control product technologies used by existing customers ; · broadening our product and service offerings through the acquisition of innovative and complementary technologies and solutions in medical and advanced industrial technology applications ; · upgrading our existing operations to expand profit margins and improve customer satisfaction by implementing lean manufacturing principles and strategic sourcing across our major production sites ; and · attracting , retaining , and developing talented and motivated employees . 24 significant events and updates acquisition of jadak on march 14 , 2014 , we completed the acquisition of jadak llc , jadak technologies inc. and advance data capture corporation ( together , “ jadak ” ) , a north syracuse , new york-based provider of optical data collection and machine vision technologies to oem medical device manufacturers , for $ 93.7 million in cash , net of working capital adjustments . the addition of the jadak technology platforms expands our portfolio of highly-differentiated enabling technologies . jadak provides data collection and machine vision solutions to its customers , which primarily consist of oem medical device manufacturers . jadak 's products are based on technologies that include barcode components and scanners , machine vision cameras , rfid technology , magnetic stripe readers , portable platforms and associated software . jadak 's products are highly engineered , application-specific components that are developed and manufactured to meet the extremely high performance and quality requirements of major medical oems . jadak 's products are used in medical equipment to increase safety and reduce medical errors by verifying patient identity , validating the specified therapy or function , and enhancing the accuracy of the medical procedure . discontinued operations on july 15 , 2014 , we completed the sale of our scientific lasers business operating under the continuum brand name for $ 6.5 million in cash , net of working capital adjustments , and recognized a $ 1.7 million loss on sale , net of tax , in the consolidated statement of operations . the loss from discontinued operations of $ 5.6 million during 2014 includes a $ 3.0 million fair value write-down of the scientific lasers business to its estimated fair value less cost to sell . the scientific lasers purchase and sale agreement requires $ 1.5 million of the sales proceeds to be held in escrow that can be utilized as indemnification for certain representations and warranties claims against the company until the expiration of the escrow arrangement in january 2016. the company has recorded the $ 1.5 million escrow in other long term assets on the consolidated balance sheet . we began to report the scientific lasers business as discontinued operations in the first quarter of 2014. as a result , prior period information related to the business has been reclassified into discontinued operations to conform to current period presentation . see notes 1 and 4 to our consolidated financial statements for further information . nds escrow recovery on january 15 , 2013 , we completed the acquisition of nds surgical imaging llc ( “ nds ” ) , a san jose , california-based company that designs , manufactures , and markets high definition visualization solutions and imaging informatics products for the surgical , patient monitoring and radiology end-markets , for $ 80.8 million in cash , net of working capital adjustments . on september 24 , 2014 , we received a payment of $ 5.4 million , the full remaining amount held in the escrow account established upon the closing of the acquisition . the escrow recovery resulted from the company 's claims for a breach of certain terms of the january 15 , 2013 securities purchase agreement for the acquisition of nds . the escrow recovery was accounted for as a reduction to goodwill as the $ 5.4 million payment was clearly and directly related to the acquisition price . the escrow recovery resulted in a final adjusted purchase price of $ 75.4 million . nds impairment charge during the fourth quarter of 2014 , the company recorded a non-cash impairment charge of $ 41.4 million related to our nds business in the consolidated financial statements for the year ended december 31 , 2014. the impairment charge will not result in future cash expenditures , or otherwise impact the company 's liquidity , cash flows , or compliance with its debt covenants . overview of financial results total sales for 2014 were $ 364.7 million , an increase of $ 47.8 million , or 15.1 % , versus the prior year primarily as a result of the jadak acquisition which accounted for $ 45.4 million or 14.3 % of the increase in total sales . in addition , foreign exchange rates favorably impacted our sales by 0.1 % during the year ended december 31 , 2014. excluding the impact of the jadak acquisition and changes in foreign exchange rates , total sales for 2014 increased 0.7 % versus the prior year . our organic sales growth is summarized as follows : % change 2014 vs. 2013 reported growth 15.1 % less : change attributable to jadak acquisition 14.3 % less : change due to foreign currency 0.1 % organic growth 0.7 % 25 the organic growth in our sales for the year ended december 31 , 2014 compared to the prior year was primarily attributable to growth in our laser products and precision motion segments offset by a decline in sales in our medical technologies segment . the increase in sales in our laser products segment was attributable to an increase in sales volume across our product portfolio . the growth in our precision motion segment was driven by increases in sales volume of optical encoders products . these increases were partially offset by a decline in sales in our medical technologies segment related to our visualization solutions product line . story_separator_special_tag 2013 compared with 2012 corporate , shared services and unallocated costs for 2013 were consistent with 2012. interest income ( expense ) , foreign exchange transaction gains ( losses ) , and other income ( expense ) , net the following table sets forth interest income ( expense ) , net , foreign exchange transaction gains ( losses ) , net and other income ( expense ) , net for 2014 , 2013 and 2012 ( in thousands ) : replace_table_token_12_th interest income ( expense ) , net 2014 compared with 2013 the increase in net interest expense in 2014 versus the prior year was the result of higher average debt levels and higher average interest rates during 2014. the higher debt levels in 2014 were the result of borrowings to fund the jadak acquisition in march 2014. the weighted average interest rate on our senior credit facilities was 3.25 % and 2.83 % during 2014 and 2013 , respectively . included in net interest expense was non-cash interest expense of approximately $ 1.0 million and $ 0.9 million in 2014 and 2013 , respectively , related to amortization of deferred financing costs on our debt . 2013 compared with 2012 the increase in net interest expense from 2012 to 2013 was the result of higher average debt outstanding during 2013 , which was partially offset by lower average interest rates . the higher debt levels in 2013 were the result of borrowings to fund the nds acquisition in january 2013. the weighted average interest rate on the senior credit facilities was 2.83 % and 3.35 % during 2013 and 2012 , respectively . included in net interest expense was non-cash interest expense of $ 0.9 million and $ 1.0 million in 2013 and 2012 , respectively , related to amortization of deferred financing costs on our debt . foreign exchange transaction gains ( losses ) , net foreign exchange transaction gains ( losses ) , net , were $ 1.3 million , ( $ 1.3 ) million and ( $ 1.3 ) million during 2014 , 2013 and 2012 , respectively , due to the performance of the u.s. dollar against the euro , british pound and japanese yen . other income ( expense ) , net other income ( expense ) , net , was $ 2.7 million , $ 1.5 million and $ 0.6 million in 2014 , 2013 and 2012 , respectively . other income ( expense ) , net , increased as a result of higher earnings from our equity-method investment in laser quantum and an increase in ownership . as a result of a share buy-back program by laser quantum , our equity ownership percentage increased from 25.1 % to 41.2 % during the second quarter of 2013 . 32 the summarized financial information for laser quantum is as follows ( in thousands ) : replace_table_token_13_th income taxes 2014 compared with 2013 we recorded a tax benefit of $ 1.0 million in 2014 , as compared to a tax expense of $ 6.2 million in 2013. the effective tax rate for 2014 was 5.6 % of loss before taxes , compared to an effective tax rate of 38.3 % of income before taxes for 2013. our effective tax rate in 2014 differs from the canadian statutory rate of 27.0 % primarily due to $ 4.6 million additional valuation allowance on net operating losses in canada and certain other jurisdictions , which was partially offset by $ 1.1 million of international tax rate differences and a $ 1.7 million benefit associated with r & d tax credits generated during the year . as a significant portion of the nds goodwill and intangible assets impairment charge was recognized in canada , we had a $ 20.2 million loss before taxes in canada in 2014 where we do not recognize any tax benefit as a result of the full valuation allowance on deferred tax assets . this significantly reduced the income tax benefit as a percentage of the loss before taxes as reported in the consolidated statement of operations for 2014 . 2013 compared with 2012 we recorded a tax expense of $ 6.2 million in 2013 , as compared to a tax benefit of $ 11.6 million in 2012. the effective tax rate for 2013 was 38.3 % of income before taxes , compared to an effective tax rate of ( 69.4 % ) of income before taxes for 2012. our tax rate in 2013 differs from the canadian statutory rate of 26.0 % primarily due to additional valuation allowance on net operating losses in certain jurisdictions offset by a tax benefit for tax credits generated during the year . discontinued operations 2014 compared with 2013 loss from discontinued operations , net of tax , was $ 7.3 million and $ 2.7 million during 2014 and 2013 , respectively . the increase in the loss from discontinued operations was primarily due to the sale of the scientific lasers business , which resulted in a $ 3.0 million fair value write-down of the scientific lasers business and an impairment charge of $ 0.5 million in connection with our joint venture investment in excel laser technology private limited , which is part of our scientific lasers business . in july 2014 , we completed the sale of the scientific lasers business for $ 6.5 million in cash , net of working capital adjustments . we recorded a $ 1.7 million loss on the sale , net of tax , in the consolidated statement of operations . 2013 compared with 2012 loss from discontinued operations , net of tax , was $ 2.7 million and $ 8.7 million during 2013 and 2012 , respectively . the decrease in the loss was primarily due to the sale of the semiconductor systems and laser systems businesses in may 2013 and october 2012 , respectively , offset by severance paid to semiconductor systems employees during 2013 as a result of the sale

cash flows cash and cash equivalents totaled $ 51.1 million at december 31 , 2014 , versus $ 61.0 million at december 31 , 2013. the net decrease in cash and cash equivalents is primarily related to cash outflows for the acquisition of jadak of $ 93.7 million , repayments of our debt of $ 33.5 million , and capital expenditures of $ 6.3 million . these outflows were offset by net cash inflows from operating activities of $ 42.3 million , borrowings of $ 77.0 million under our senior credit facilities , proceeds of $ 5.4 million related to the recovery of an escrow claim for the acquisition of nds and net cash proceeds from the sale of our scientific lasers business totaling $ 4.7 million . the following table summarizes our cash and cash equivalent balances , cash flows and unused and available funds on our revolving credit facility for the years indicated ( in thousands ) : replace_table_token_15_th operating cash flows cash provided by operating activities of continuing operations was $ 44.0 million in 2014 versus $ 56.2 million and $ 33.1 million in 2013 and 2012 , respectively . cash provided by operating activities of continuing operations decreased in 2014 by $ 12.2 million primarily due to net tax refunds of $ 11.8 million received in 2013 as a result of the settlement with the irs .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```cash flows cash and cash equivalents totaled $ 51.1 million at december 31 , 2014 , versus $ 61.0 million at december 31 , 2013. the net decrease in cash and cash equivalents is primarily related to cash outflows for the acquisition of jadak of $ 93.7 million , repayments of our debt of $ 33.5 million , and capital expenditures of $ 6.3 million . these outflows were offset by net cash inflows from operating activities of $ 42.3 million , borrowings of $ 77.0 million under our senior credit facilities , proceeds of $ 5.4 million related to the recovery of an escrow claim for the acquisition of nds and net cash proceeds from the sale of our scientific lasers business totaling $ 4.7 million . the following table summarizes our cash and cash equivalent balances , cash flows and unused and available funds on our revolving credit facility for the years indicated ( in thousands ) : replace_table_token_15_th operating cash flows cash provided by operating activities of continuing operations was $ 44.0 million in 2014 versus $ 56.2 million and $ 33.1 million in 2013 and 2012 , respectively . cash provided by operating activities of continuing operations decreased in 2014 by $ 12.2 million primarily due to net tax refunds of $ 11.8 million received in 2013 as a result of the settlement with the irs .
```    
 Suspicious Activity Report : target customers and , acquisitions of additional motion control product technologies used by existing customers ; · broadening our product and service offerings through the acquisition of innovative and complementary technologies and solutions in medical and advanced industrial technology applications ; · upgrading our existing operations to expand profit margins and improve customer satisfaction by implementing lean manufacturing principles and strategic sourcing across our major production sites ; and · attracting , retaining , and developing talented and motivated employees . 24 significant events and updates acquisition of jadak on march 14 , 2014 , we completed the acquisition of jadak llc , jadak technologies inc. and advance data capture corporation ( together , “ jadak ” ) , a north syracuse , new york-based provider of optical data collection and machine vision technologies to oem medical device manufacturers , for $ 93.7 million in cash , net of working capital adjustments . the addition of the jadak technology platforms expands our portfolio of highly-differentiated enabling technologies . jadak provides data collection and machine vision solutions to its customers , which primarily consist of oem medical device manufacturers . jadak 's products are based on technologies that include barcode components and scanners , machine vision cameras , rfid technology , magnetic stripe readers , portable platforms and associated software . jadak 's products are highly engineered , application-specific components that are developed and manufactured to meet the extremely high performance and quality requirements of major medical oems . jadak 's products are used in medical equipment to increase safety and reduce medical errors by verifying patient identity , validating the specified therapy or function , and enhancing the accuracy of the medical procedure . discontinued operations on july 15 , 2014 , we completed the sale of our scientific lasers business operating under the continuum brand name for $ 6.5 million in cash , net of working capital adjustments , and recognized a $ 1.7 million loss on sale , net of tax , in the consolidated statement of operations . the loss from discontinued operations of $ 5.6 million during 2014 includes a $ 3.0 million fair value write-down of the scientific lasers business to its estimated fair value less cost to sell . the scientific lasers purchase and sale agreement requires $ 1.5 million of the sales proceeds to be held in escrow that can be utilized as indemnification for certain representations and warranties claims against the company until the expiration of the escrow arrangement in january 2016. the company has recorded the $ 1.5 million escrow in other long term assets on the consolidated balance sheet . we began to report the scientific lasers business as discontinued operations in the first quarter of 2014. as a result , prior period information related to the business has been reclassified into discontinued operations to conform to current period presentation . see notes 1 and 4 to our consolidated financial statements for further information . nds escrow recovery on january 15 , 2013 , we completed the acquisition of nds surgical imaging llc ( “ nds ” ) , a san jose , california-based company that designs , manufactures , and markets high definition visualization solutions and imaging informatics products for the surgical , patient monitoring and radiology end-markets , for $ 80.8 million in cash , net of working capital adjustments . on september 24 , 2014 , we received a payment of $ 5.4 million , the full remaining amount held in the escrow account established upon the closing of the acquisition . the escrow recovery resulted from the company 's claims for a breach of certain terms of the january 15 , 2013 securities purchase agreement for the acquisition of nds . the escrow recovery was accounted for as a reduction to goodwill as the $ 5.4 million payment was clearly and directly related to the acquisition price . the escrow recovery resulted in a final adjusted purchase price of $ 75.4 million . nds impairment charge during the fourth quarter of 2014 , the company recorded a non-cash impairment charge of $ 41.4 million related to our nds business in the consolidated financial statements for the year ended december 31 , 2014. the impairment charge will not result in future cash expenditures , or otherwise impact the company 's liquidity , cash flows , or compliance with its debt covenants . overview of financial results total sales for 2014 were $ 364.7 million , an increase of $ 47.8 million , or 15.1 % , versus the prior year primarily as a result of the jadak acquisition which accounted for $ 45.4 million or 14.3 % of the increase in total sales . in addition , foreign exchange rates favorably impacted our sales by 0.1 % during the year ended december 31 , 2014. excluding the impact of the jadak acquisition and changes in foreign exchange rates , total sales for 2014 increased 0.7 % versus the prior year . our organic sales growth is summarized as follows : % change 2014 vs. 2013 reported growth 15.1 % less : change attributable to jadak acquisition 14.3 % less : change due to foreign currency 0.1 % organic growth 0.7 % 25 the organic growth in our sales for the year ended december 31 , 2014 compared to the prior year was primarily attributable to growth in our laser products and precision motion segments offset by a decline in sales in our medical technologies segment . the increase in sales in our laser products segment was attributable to an increase in sales volume across our product portfolio . the growth in our precision motion segment was driven by increases in sales volume of optical encoders products . these increases were partially offset by a decline in sales in our medical technologies segment related to our visualization solutions product line . story_separator_special_tag 2013 compared with 2012 corporate , shared services and unallocated costs for 2013 were consistent with 2012. interest income ( expense ) , foreign exchange transaction gains ( losses ) , and other income ( expense ) , net the following table sets forth interest income ( expense ) , net , foreign exchange transaction gains ( losses ) , net and other income ( expense ) , net for 2014 , 2013 and 2012 ( in thousands ) : replace_table_token_12_th interest income ( expense ) , net 2014 compared with 2013 the increase in net interest expense in 2014 versus the prior year was the result of higher average debt levels and higher average interest rates during 2014. the higher debt levels in 2014 were the result of borrowings to fund the jadak acquisition in march 2014. the weighted average interest rate on our senior credit facilities was 3.25 % and 2.83 % during 2014 and 2013 , respectively . included in net interest expense was non-cash interest expense of approximately $ 1.0 million and $ 0.9 million in 2014 and 2013 , respectively , related to amortization of deferred financing costs on our debt . 2013 compared with 2012 the increase in net interest expense from 2012 to 2013 was the result of higher average debt outstanding during 2013 , which was partially offset by lower average interest rates . the higher debt levels in 2013 were the result of borrowings to fund the nds acquisition in january 2013. the weighted average interest rate on the senior credit facilities was 2.83 % and 3.35 % during 2013 and 2012 , respectively . included in net interest expense was non-cash interest expense of $ 0.9 million and $ 1.0 million in 2013 and 2012 , respectively , related to amortization of deferred financing costs on our debt . foreign exchange transaction gains ( losses ) , net foreign exchange transaction gains ( losses ) , net , were $ 1.3 million , ( $ 1.3 ) million and ( $ 1.3 ) million during 2014 , 2013 and 2012 , respectively , due to the performance of the u.s. dollar against the euro , british pound and japanese yen . other income ( expense ) , net other income ( expense ) , net , was $ 2.7 million , $ 1.5 million and $ 0.6 million in 2014 , 2013 and 2012 , respectively . other income ( expense ) , net , increased as a result of higher earnings from our equity-method investment in laser quantum and an increase in ownership . as a result of a share buy-back program by laser quantum , our equity ownership percentage increased from 25.1 % to 41.2 % during the second quarter of 2013 . 32 the summarized financial information for laser quantum is as follows ( in thousands ) : replace_table_token_13_th income taxes 2014 compared with 2013 we recorded a tax benefit of $ 1.0 million in 2014 , as compared to a tax expense of $ 6.2 million in 2013. the effective tax rate for 2014 was 5.6 % of loss before taxes , compared to an effective tax rate of 38.3 % of income before taxes for 2013. our effective tax rate in 2014 differs from the canadian statutory rate of 27.0 % primarily due to $ 4.6 million additional valuation allowance on net operating losses in canada and certain other jurisdictions , which was partially offset by $ 1.1 million of international tax rate differences and a $ 1.7 million benefit associated with r & d tax credits generated during the year . as a significant portion of the nds goodwill and intangible assets impairment charge was recognized in canada , we had a $ 20.2 million loss before taxes in canada in 2014 where we do not recognize any tax benefit as a result of the full valuation allowance on deferred tax assets . this significantly reduced the income tax benefit as a percentage of the loss before taxes as reported in the consolidated statement of operations for 2014 . 2013 compared with 2012 we recorded a tax expense of $ 6.2 million in 2013 , as compared to a tax benefit of $ 11.6 million in 2012. the effective tax rate for 2013 was 38.3 % of income before taxes , compared to an effective tax rate of ( 69.4 % ) of income before taxes for 2012. our tax rate in 2013 differs from the canadian statutory rate of 26.0 % primarily due to additional valuation allowance on net operating losses in certain jurisdictions offset by a tax benefit for tax credits generated during the year . discontinued operations 2014 compared with 2013 loss from discontinued operations , net of tax , was $ 7.3 million and $ 2.7 million during 2014 and 2013 , respectively . the increase in the loss from discontinued operations was primarily due to the sale of the scientific lasers business , which resulted in a $ 3.0 million fair value write-down of the scientific lasers business and an impairment charge of $ 0.5 million in connection with our joint venture investment in excel laser technology private limited , which is part of our scientific lasers business . in july 2014 , we completed the sale of the scientific lasers business for $ 6.5 million in cash , net of working capital adjustments . we recorded a $ 1.7 million loss on the sale , net of tax , in the consolidated statement of operations . 2013 compared with 2012 loss from discontinued operations , net of tax , was $ 2.7 million and $ 8.7 million during 2013 and 2012 , respectively . the decrease in the loss was primarily due to the sale of the semiconductor systems and laser systems businesses in may 2013 and october 2012 , respectively , offset by severance paid to semiconductor systems employees during 2013 as a result of the sale

